These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 39017931)
21. A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles. Teymouri S; Pourhajibagher M; Bahador A Mol Biol Rep; 2024 Oct; 51(1):1044. PubMed ID: 39377967 [TBL] [Abstract][Full Text] [Related]
22. Evolutionary Rationale for Phages as Complements of Antibiotics. Torres-Barceló C; Hochberg ME Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863 [TBL] [Abstract][Full Text] [Related]
26. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope. Kulshrestha M; Tiwari M; Tiwari V Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110 [TBL] [Abstract][Full Text] [Related]
27. Preliminary survey of local bacteriophages with lytic activity against multi-drug resistant bacteria. Latz S; Wahida A; Arif A; Häfner H; Hoß M; Ritter K; Horz HP J Basic Microbiol; 2016 Oct; 56(10):1117-1123. PubMed ID: 27194637 [TBL] [Abstract][Full Text] [Related]
28. Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative. Mende K; Akers KS; Tyner SD; Bennett JW; Simons MP; Blyth DM; Li P; Stewart L; Tribble DR Mil Med; 2022 May; 187(Suppl 2):42-51. PubMed ID: 35512375 [TBL] [Abstract][Full Text] [Related]
29. Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii. Bagińska N; Pichlak A; Górski A; Jończyk-Matysiak E Virol Sin; 2019 Aug; 34(4):347-357. PubMed ID: 31093881 [TBL] [Abstract][Full Text] [Related]
30. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa. Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246 [TBL] [Abstract][Full Text] [Related]
31. Current Knowledge and Perspectives of Phage Therapy for Combating Refractory Wound Infections. Wang B; Du L; Dong B; Kou E; Wang L; Zhu Y Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791502 [TBL] [Abstract][Full Text] [Related]
32. Genetic mechanisms and correlated risk factors of antimicrobial-resistant ESKAPEE pathogens isolated in a tertiary hospital in Malaysia. Ngoi ST; Chong CW; Ponnampalavanar SSS; Tang SN; Idris N; Abdul Jabar K; Gregory MJ; Husain T; Teh CSJ Antimicrob Resist Infect Control; 2021 Apr; 10(1):70. PubMed ID: 33892804 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections. Siopi M; Skliros D; Paranos P; Koumasi N; Flemetakis E; Pournaras S; Meletiadis J Clin Microbiol Rev; 2024 Sep; 37(3):e0004424. PubMed ID: 39072666 [TBL] [Abstract][Full Text] [Related]
35. Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii. Oyejobi GK; Xiong D; Shi M; Zhang X; Yang H; Xue H; Ogolla F; Wei H J Bacteriol; 2022 Mar; 204(3):e0059321. PubMed ID: 35156836 [TBL] [Abstract][Full Text] [Related]
36. Phage therapy combats pan drug-resistant Acinetobacter baumannii infection safely and efficiently. Wang WX; Wu JZ; Zhang BL; Yu JY; Han LM; Lu XL; Li H; Fu SY; Ren YY; Dong H; Xu Y; Wang GT; Gao JH; Wang C; Chen XZ; Liu DX; Huang Y; Yu JH; Wang SW; Yang YF; Chen W Int J Antimicrob Agents; 2024 Aug; 64(2):107220. PubMed ID: 38810939 [TBL] [Abstract][Full Text] [Related]
37. Environmental Phage-Based Cocktail and Antibiotic Combination Effects on Grygorcewicz B; Wojciuk B; Roszak M; Łubowska N; Błażejczak P; Jursa-Kulesza J; Rakoczy R; Masiuk H; Dołęgowska B Microb Drug Resist; 2021 Jan; 27(1):25-35. PubMed ID: 32543337 [TBL] [Abstract][Full Text] [Related]
38. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria. Rohde C; Wittmann J; Kutter E Surg Infect (Larchmt); 2018; 19(8):737-744. PubMed ID: 30256176 [TBL] [Abstract][Full Text] [Related]
39. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens. Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428 [TBL] [Abstract][Full Text] [Related]
40. Exploiting Broad-Spectrum Chimeric Lysin to Cooperate with Mupirocin against Staphylococcus aureus-Induced Skin Infections and Delay the Development of Mupirocin Resistance. Duan XC; Li XX; Li XM; Wang S; Zhang FQ; Qian P Microbiol Spectr; 2023 Jun; 11(3):e0505022. PubMed ID: 37125939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]